Compass Wealth Management LLC Reduces Stock Holdings in CVS Health Corporation (NYSE:CVS)

Compass Wealth Management LLC cut its stake in CVS Health Corporation (NYSE:CVS - Free Report) by 51.3% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,084 shares of the pharmacy operator's stock after selling 4,300 shares during the quarter. Compass Wealth Management LLC's holdings in CVS Health were worth $277,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CVS. Dodge & Cox increased its holdings in shares of CVS Health by 11.2% in the fourth quarter. Dodge & Cox now owns 70,105,899 shares of the pharmacy operator's stock worth $3,147,054,000 after purchasing an additional 7,075,209 shares during the period. Capital World Investors raised its holdings in shares of CVS Health by 26.6% in the 4th quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator's stock valued at $2,739,927,000 after acquiring an additional 12,819,148 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of CVS Health by 2.6% during the 4th quarter. Geode Capital Management LLC now owns 27,051,540 shares of the pharmacy operator's stock valued at $1,211,582,000 after acquiring an additional 689,867 shares during the last quarter. Capital International Investors grew its holdings in shares of CVS Health by 4.8% during the fourth quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator's stock worth $1,196,989,000 after purchasing an additional 1,212,126 shares in the last quarter. Finally, Pzena Investment Management LLC raised its stake in CVS Health by 49.3% in the fourth quarter. Pzena Investment Management LLC now owns 19,610,579 shares of the pharmacy operator's stock valued at $880,319,000 after purchasing an additional 6,475,271 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Up 1.2%

Shares of CVS traded up $0.78 during trading hours on Friday, hitting $67.38. The company had a trading volume of 3,770,987 shares, compared to its average volume of 10,851,185. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $72.51. The firm has a fifty day moving average price of $65.11 and a 200-day moving average price of $61.58. The stock has a market capitalization of $85.23 billion, a price-to-earnings ratio of 16.08, a P/E/G ratio of 0.97 and a beta of 0.57. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. During the same period in the previous year, the company earned $1.31 earnings per share. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. On average, equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

Insider Activity at CVS Health

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was acquired at an average price of $63.70 per share, with a total value of $100,009.00. Following the transaction, the director owned 12,007 shares in the company, valued at $764,845.90. This represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. 1.22% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Jefferies Financial Group increased their price objective on CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research report on Monday, June 30th. Royal Bank Of Canada raised their price objective on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a report on Monday, May 5th. Piper Sandler upped their price objective on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. Finally, Robert W. Baird lifted their target price on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and a consensus price target of $75.06.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.